Brain natriuretic peptide as bridge to therapy for heart failure

This publication has 12 references indexed in Scilit:

• Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy
  American Heart Journal, 1999
• Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1
  European Heart Journal, 1999
• Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure
  American Heart Journal, 1999
• Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation
  European Journal of Clinical Investigation, 1998
• Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular Hypertrophy
  Hypertension, 1996
• Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern
  European Heart Journal, 1996
• Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathy
  The American Journal of Cardiology, 1990
• Atrial natriuretic factor. Is it physiologically important?
  Circulation, 1990
• Plasma atrial natriuretic polypeptide as an index of left ventricular end-diastolic pressure in patients with chronic left-sided heart failure
  American Heart Journal, 1989
• Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor.
  Circulation Research, 1988